arBtrage CAPITALIZING MARKETS checking… Sign in

Sutro Biopharma, Inc.

STRO Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$26.09
▼ -9.0% Today
as of Jun 7, 07:28 ET
Last 30 days -24.79% Apr 28 → Jun 05
$23.11 $27.89 $32.67 $37.45 $42.23 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$28.47
High
$28.67
Low
$25.80
Volume
$294,036
Avg Vol
$143,661
Mkt Cap
$491M
P/E (TTM)
Beta
52w High
$43.85
52w Low
$6.70
Div Yield
Shares Out
$17M

Overview

52-week range
$6.70
$44
52% of range
Avg surprise (last 2)
-35.6%
Avg reaction (last 2)
-3.0%
0% positive
Latest IV / EM
166%
EM ±23.0% · $25 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.94$-2.24$-1.54$-0.84$-0.14 Actual $-0.64Actual $-0.81Actual $-0.59Actual $-0.59Actual $-0.59Actual $-0.91Est $-0.63Actual $-0.14Actual $-0.67Actual $-2.94Est $-2.32 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-76M$-60M$-44M$-28M$-12M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-2.94 $-2.32 -26.7% -223.1% -3.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.67 financials
Mon Jun 30, 2025Jun 2025 $-0.14 financials
Thu May 8, 2025Mar/2025 $-0.91 $-0.63 -44.4% -3.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.59 financials
Sun Jun 30, 2024Jun 2024 $-0.59 financials
Sun Mar 31, 2024Mar 2024 $-0.59 financials
Sat Sep 30, 2023Sep 2023 $-0.81 financials
Fri Jun 30, 2023Jun 2023 $-0.64 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-30M$-48M$-3M$-69M$-68M$-49M
Net income$-38M$-57M$-11M$-76M$-49M$-48M
EPS (diluted)$-2.94$-0.67$-0.14$-9.08$-0.59$-0.59

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$74M$58M$66M$64M$106M$190M$175M$91M
Inventory
Total current assets$221M$151M$182M$232M$287M$343M$406M$443M
Total assets$242M$174M$210M$262M$321M$387M$452M$489M
Long-term debt
Total liabilities$309M$306M$297M$294M$347M$343M$341M$337M
Total equity$-67M$-132M$-87M$-32M$-26M$45M$111M$152M

Implied volatility — last 90 days

161%163%166%168%171% Jun 07 — IV 166% · EM ±23.0%

Sector peers